Xbrane Biopharma AB (publ) (STO:XBRANE)
10.35
-0.30 (-2.82%)
Nov 20, 2026, 5:29 PM CET
Xbrane Biopharma AB Revenue
Xbrane Biopharma AB had revenue of 54.78M SEK in the quarter ending September 30, 2026, with 441.31% growth. This brings the company's total for the last twelve months to 127.95M, down -38.80% year-over-year. In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M with 2.87% growth. That makes Xbrane Biopharma AB the 36,377th largest company in the world by revenue and 489th in Sweden.
Revenue (ttm)
127.95M
Revenue Growth
-38.80%
P/S Ratio
1.67
Revenue / Employee
4.57M
Employees
28
Market Cap
213.27M
Revenue by Geography
- India 84.30M 55.3%
- Germany 67.50M 44.3%
- Others 600.00K 0.4%
Fiscal year ended Dec 31, 2025 See the full Xbrane Biopharma AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 152.35M | 4.26M | 2.87% |
| Dec 31, 2024 | 148.10M | -90.63M | -37.96% |
| Dec 31, 2023 | 238.73M | 181.11M | 314.33% |
| Dec 31, 2022 | 57.62M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 20.49M | -286.00K | -1.38% |
| Dec 31, 2017 | 20.77M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 392.86K | 203.23K | 107.17% |
| Dec 31, 2014 | 189.63K | 104.00 | 0.05% |
| Dec 31, 2013 | 189.52K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.31M |
| BioInvent International AB | 39.98M |
| Intervacc AB | 17.35M |
| Corline Biomedical AB | 13.44M |
| Abera Bioscience AB | 9.10M |
| Elicera Therapeutics AB | 7.79M |
| Simris Group AB (PUBL) | 1.14M |
| Diamyd Medical AB | 477.00K |
Xbrane Biopharma AB News
- Just now - Xbrane Biopharma AB Slides: Q4 2026 - Filings
- 18 days ago - Xbrane Biopharma AB Transcript: BioStock Life Science Summit 2026 - Transcripts
- 23 days ago - Xbrane Biopharma AB Earnings Call Transcript: Q3 2026 - Transcripts
- 23 days ago - Xbrane Biopharma AB Quarterly report: Q3 2026 - Filings
- 23 days ago - Xbrane Biopharma AB Slides: Q3 2026 - Filings
- 4 months ago - Xbrane Biopharma AB Earnings Call Transcript: Q2 2026 - Transcripts
- 4 months ago - Xbrane Biopharma AB Quarterly report: Q2 2026 - Filings
- 4 months ago - Xbrane Biopharma AB Slides: Q2 2026 - Filings